Overview

Anesthesia and Circulating Tumor Cells in Breast Cancer

Status:
Completed
Trial end date:
2018-04-01
Target enrollment:
Participant gender:
Summary
Serious concern about the role of anesthesia in tumor recurrence has considerably risen over years, but the lack of surrogate markers for tumor spreading made trials addressing this issue difficult to realize. In breast cancer patients CTC positivity has been recently recognized as an independent prognostic factor. In this respect, we postulated that in a first step changes in the number of CTC after general anesthesia would help to determine the effect of anesthesia on this tumor marker.
Phase:
Phase 4
Details
Lead Sponsor:
University of Zurich
Treatments:
Anesthetics
Propofol
Sevoflurane